Select Medical Holdings (SEM) Cash from Financing Activities (2018 - 2026)

Select Medical Holdings (SEM) has 9 years of Cash from Financing Activities data on file, last reported at $18.0 million in Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at $18.0 million, down 63.57% year-over-year; the trailing twelve-month figure through Mar 2026 was -$194.5 million (up 50.74% YoY), and the FY2025 annual result was -$163.2 million, up 47.57% from the prior year.
• Cash from Financing Activities improved to $18.0 million in Q1 2026 per SEM's latest filing, from -$31.0 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $133.0 million in Q1 2024 and troughed at -$205.5 million in Q2 2024.
• A 5-year average of -$48.2 million and a median of -$46.5 million in 2025 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities slumped 400.5% in 2023, then jumped 3788.86% in 2024.
• A 5-year view of Cash from Financing Activities shows it stood at $34.4 million in 2022, then tumbled by 400.5% to -$103.3 million in 2023, then sank by 77.18% to -$183.0 million in 2024, then surged by 83.08% to -$31.0 million in 2025, then jumped by 157.99% to $18.0 million in 2026.
• Business Quant data shows SEM's Cash from Financing Activities at $18.0 million in Q1 2026, -$31.0 million in Q4 2025, and -$135.0 million in Q3 2025.